NHS could offer weight-loss jabs at pharmacies ‘for £9.90 prescription price'
Weight loss jabs may be available to patients following a short over-the-counter consultation in a pharmacy, according to reports.
Drugs such as Ozempic, Wegovy and Mounjaro could be offered at an NHS prescription price of £9.90, rather than the current charge of around £150 for patients who buy the medicines through private providers.
Currently, NHS prescriptions of the injections are restricted to those regarded as having the highest clinical need.
There is currently a two-year waiting list for Wegovy on the health service and about a third of adults living in England are obese.
Some experts argue that offering jabs at a prescription price in pharmacies would make them more accessible to the millions of Britons who could improve their health by taking the drugs.
And now, a multi-million pound deal is set to be struck with a major pharmaceutical firm to fund a pilot scheme across the UK, according a Daily Mail report.
A government spokesperson said: 'As the government shifts the NHS from sickness to prevention, we will be looking across the board at how these drugs can be made available to more people who can benefit from them.
"The NHS is already tackling obesity in innovative ways, including through community care models and digital technologies, to help deliver these drugs as part of a rounded package of care."
Weight loss jabs such as Mounjaro and Wegovy work by mimicking a natural hormone and making people feel fuller for longer.
People can lose up to 15 per cent of their body weight within months using the drug.
Estimates from the National Institute for Health Care and Excellence (NICE) suggest 3.4 million people could benefit from taking weight loss jabs.
Health experts have also warned that obesity drugs are not a 'quick fix' and should only be used under medical supervision.
'We must remember that whilst weight loss medications can play an important role in efforts to tackle obesity, they are not a quick fix, and they are not suitable for everyone,' Thorrun Govind, Pharmacist and health expert told The Independent.
However, she explained that pharmacists are 'well-equipped' to offer the drugs.
She said: 'Pharmacists are highly trained, regulated professionals who are well-equipped to support patients in accessing treatments safely. By making medicines available through pharmacies, we can reduce the risk of people turning to unsafe, unregulated sources and ensure they receive trusted advice and clinical oversight.'
Pharmacist Dr Leyla Hannbeck also stressed the importance of accessing weight loss jabs from professionals and not from unknown sources online.
Dr Hannbeck, chief executive of the Independent Pharmacies Association told The Independent: 'This is a move in the right direction. Community pharmacies are well-placed in providing this this service and also advise patients on healthy lifestyle.
'Weight loss, for patient safety reasons should always be done in the face-to-face presence of health care professionals such as doctors and pharmacists and not online at a distance.'
Obesity is estimated to cost the NHS £6bn a year. It is linked to a range of health risks from type 2 diabetes and heart disease to some types of cancer.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Scottish Sun
an hour ago
- Scottish Sun
New ‘Ozempic pill' is better than ‘skinny jabs' and helps you lose weight even faster, study suggests
The new weight loss pill has seen promising results and offers hope to millions WEIGH TO GO New 'Ozempic pill' is better than 'skinny jabs' and helps you lose weight even faster, study suggests Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) A NEW 'Ozempic pill' leads to faster weight loss than the popular 'skinny jabs', studies have suggested. The new weight loss medication, which can also be offered by injection, can help patients lose a significant amount of weight. Sign up for Scottish Sun newsletter Sign up 1 The new weight loss pill has seen promising results in early trials Credit: Getty An early study found that patients who received amycretin as a weekly jab lost 24% of their body weight after 36 weeks of treatment. But initial trials assessing a tablet form of the jab saw promising results with patients losing an average 13% of bodyweight in just three months. This suggests the drug leads to greater weight loss than Wegovy, the 'sister jab' of Ozempic. Such treatments have been called transformative by NHS leaders. It's estimated that around 1.5 million Brits currently receive weight loss jabs through specialist weight loss services or private prescriptions. But weight pills offer a new hope to millions looking to lose weight as the injections put additional pressure on an overstretched NHS. However, further clinical trials are needed before the treatment can be made available in the UK. This could take several years and there's no guarantee that regulators will approve the use of the drug. Amycretin, made by Novo Nordisk, contains semaglutide, the same active ingredient as Ozempic and Wegovy and helps control blood sugar and appetite. It targets specific receptors in the body - the GLP-1 and amylin receptors - helping you feel full and stops overeating. An early trial published in The Lancet found that 125 adults taking weekly injections containing higher doses of the drug lost nearly a quarter of their body weight after 36 weeks. It also showed signs of improving blood sugar levels. However, there were some mild to moderate side effects including nausea and vomiting but these were resolved by the end of the treatment. Experts said that the medicine appeared "safe and tolerable" but further studies were needed to fully assess the drug. But a second trial, also published in The Lancet, assessed the drug in tablet form in 144 people. Those taking the highest dose of 100mg lost 13% of their body weight over four months. Weight Loss Jabs - Pros vs Cons The authors wrote: "Amycretin effectively lowered body weight and improved metabolic and glycaemic parameters in people who were overweight or obese. "Longer studies with more participants are warranted for evaluation of the safety and efficacy of amycretin in individuals living with obesity and type 2 diabetes, and to optimise the dosing regimen." As with the first trial, there were also some mild to moderate side effects including loss of appetite and similar gastrointestinal issues. It comes as a separate study examined the effects of the weight-loss jab, Wegovy, at higher doses. The researchers found that giving patients 7.2mg of Wegovy once a week led to an average weight loss of 21%, with a third of participants losing 25% of their body weight over 72 weeks. The studies were also presented to the American Diabetes Association's Scientific Sessions in Chicago.
The Sun
an hour ago
- The Sun
New ‘Ozempic pill' is better than ‘skinny jabs' and helps you lose weight even faster, study suggests
A NEW 'Ozempic pill' leads to faster weight loss than the popular 'skinny jabs', studies have suggested. The new weight loss medication, which can also be offered by injection, can help patients lose a significant amount of weight. An early study found that patients who received amycretin as a weekly jab lost 24% of their body weight after 36 weeks of treatment. But initial trials assessing a tablet form of the jab saw promising results with patients losing an average 13% of bodyweight in just three months. This suggests the drug leads to greater weight loss than Wegovy, the 'sister jab' of Ozempic. Such treatments have been called transformative by NHS leaders. It's estimated that around 1.5 million Brits currently receive weight loss jabs through specialist weight loss services or private prescriptions. But weight pills offer a new hope to millions looking to lose weight as the injections put additional pressure on an overstretched NHS. However, further clinical trials are needed before the treatment can be made available in the UK. This could take several years and there's no guarantee that regulators will approve the use of the drug. Amycretin, made by Novo Nordisk, contains semaglutide, the same active ingredient as Ozempic and Wegovy and helps control blood sugar and appetite. It targets specific receptors in the body - the GLP-1 and amylin receptors - helping you feel full and stops overeating. An early trial published in The Lancet found that 125 adults taking weekly injections containing higher doses of the drug lost nearly a quarter of their body weight after 36 weeks. It also showed signs of improving blood sugar levels. However, there were some mild to moderate side effects including nausea and vomiting but these were resolved by the end of the treatment. Experts said that the medicine appeared "safe and tolerable" but further studies were needed to fully assess the drug. But a second trial, also published in The Lancet, assessed the drug in tablet form in 144 people. Those taking the highest dose of 100mg lost 13% of their body weight over four months. Weight Loss Jabs - Pros vs Cons The authors wrote: "Amycretin effectively lowered body weight and improved metabolic and glycaemic parameters in people who were overweight or obese. "Longer studies with more participants are warranted for evaluation of the safety and efficacy of amycretin in individuals living with obesity and type 2 diabetes, and to optimise the dosing regimen." As with the first trial, there were also some mild to moderate side effects including loss of appetite and similar gastrointestinal issues. It comes as a separate study examined the effects of the weight-loss jab, Wegovy, at higher doses. The researchers found that giving patients 7.2mg of Wegovy once a week led to an average weight loss of 21%, with a third of participants losing 25% of their body weight over 72 weeks. The studies were also presented to the American Diabetes Association's Scientific Sessions in Chicago.
Daily Mirror
an hour ago
- Daily Mirror
Vicky Pattison makes 'worried' admission as she gives update on 'struggles'
Vicky Pattison has opened up about her "struggles" with food and admitted she has concerns over the use of weight loss jabs. The former Geordie Shore star has previously been open about her battle with "disordered eating" Vicky Pattison has candidly shared her "struggles" with food while voicing her concerns about weight loss jabs. The former queen of the jungle, known for her victory in I'm A Me Out of Here!, has previously discussed her battles with "disordered eating". The reality TV star revealed that she used to count how many blueberries were in her porridge, "restrict calories" and "weaponise exercise" during her lightest periods. Conversely, Vicky confessed to times when she "ate what she wanted" but was then "cruel" to herself. It comes as Vicky, 37, admits she has her reservations about people using weight loss jabs. The Geordie Shore alum says people using the jabs feels like a "step back" for body positivity. She expressed her "worries" about the contents of these jabs in an interview with The Sun, questioning: "I've seen women online losing weight on the skinny jabs and they're feeling great and have new-found confidence, and that sounds amazing for them, but do we really know what we're putting into our bodies? No. "I don't think we've got enough information about them, have we? That's what I'm always worried about. It feels like a bit of a step back." Vicky says it is an "absolute shame" that after years of "embracing the body positivity movement" people have started saying "I never wanted to be curvy actually, I always wanted to be skinny." Although the star has "no judgement" towards anyone deciding to take weight loss jabs. She added: "As someone who's spent her life struggling with noise around food and what people thought about us, being the big girl and all the rest of it, whatever makes people happy is none of my business." Currently in England and Wales, doctors have the option to prescribe weight loss injections on the NHS. Treatments such as Saxenda, Wegovy, and Mounjaro can be prescribed, with the latter requiring a specialist's involvement. Vicky, who tied the knot with Ercan Ramadan last year, shared three pictures of herself at different weights on Instagram in August. She used the post to open up about how she felt about her body. In the post, the celebrity penned: "I used to be cruel to the girl in the first photo... I let her eat what she wanted but I constantly berated her. Called her names and made her feel worthless. Just because of a number on a scale." The conversation continued as she reflected: "I was cruel to the girl in the second photo as well but in an entirely different way. I would count how many blueberries I put on my porridge, restrict my calories and weaponise exercise. That girl was a nervous wreck." Vicky acknowledged that she was "unhappy" when looking at both photos. She confessed that during those times, she combated "anxiety" and "disordered eating." Adding to her confession, she stated: "Both of these extremes didn't bring me happiness- the unhealthy practices I put my body through over the years brought me anxiety, disordered eating and low self worth. "And even though I'd like to think I've changed and I'm in a better place now- these pictures always serve as a stark reminder of what I put myself through. And what I don't want other women to put themselves through."
